Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial
José Marı́a Tolosana(Universitat de Barcelona), Josép Brugada(Hospital Clínic de Barcelona), Lluı́s Mont(Hospital Clínic de Barcelona), M. Heras(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Paola Berne(University of Sassari), David Tamborero(Universitat Pompeu Fabra), Begoña Benito(Universitat de Barcelona), Antonio Berruezo(Hospital Quirón Teknon)
Cited by 112
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|EP Europace|2017|1.2k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851